There was no difference between medical or surgical patients, 44.2% versus 53.6%, respectively (odds ratio 0.69, 95% confidence interval 0.38-1.24). The most common risk factors were immobilization (70.6%), infection (44.3%), cancer (27.5%), and obesity (23.3%). There were patients who received substandard care, as they had high risk of VTE. Those who had three or more risk factors, and patients with cancer, received prophylaxis in 25% and 18% of cases, respectively.
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DISCUSSION (CONCLUSION):
In agreement with previous published studies, we found low adherence to best practices. Actions have been carried out on patients with cancer and three or more risk factors. The use of an electronic template integrated in the EHR has been crucial for quality improvement. TARGET AUDIENCE(S): 1. Evidence synthesizer, developer of systematic reviews or meta-analyses 2. Guideline implementer 3. Quality improvement manager/facilitator 4. Medical educator 5. Health care policy analyst/policy-maker P3-Existing clinical assessment tools and diagnostic strategies for pulmonary embolism Natalia Lekerika-Royo, MD (Presenter) (Osakidetza, Berango, Bizkaia, Spain); Eunate Arana-Arri, PhD (Osakidetza, Barakaldo, Spain); Lorena Ló pez-Roldá n, MD (Osakidetza, Barakaldo, Spain); Larraitz García Echeberria, MD (Osakidetza, Barakaldo, Spain); Ana García Montero, MD (Osakidetza, Barakaldo, Spain); Maider Garmendia Zallo, MD (Osakidetza, Barakaldo, Spain); Ainhoa Gó mez Bonilla, MD (Osakidetza, Barakaldo, Spain); Valentin Cabriada Nuñ o, MD (Osakidetza, 48903, Spain) PRIMARY TRACK: Evidence generation and synthesis SECONDARY TRACK: Evidence appraisal BACKGROUND (INTRODUCTION): Acute pulmonary embolism (PE) is of interest to physicians of almost all disciplines, as it is encountered across the entire spectrum of clinical medicine. It is estimated that as many as 200,000 patients die annually of PE in the European Union, with similar numbers reported in the USA. In the past, management of acute PE has been characterized by a high degree of complexity and a disappointing lack of efficacy and efficiency.
LEARNING OBJECTIVES (TRAINING GOALS):
1. To summarize the evidence regarding the existing clinical probability assessment tools. 2. To analyze the diagnostic strategies and algorithms. METHODS: We performed a comprehensive review (overview), including experimental studies, protocols, guidelines, recommendations, and standards for clinical prognostic models and tools and diagnostic algorithms. The databases consulted were MEDLINE, EMBASE, Cochrane, CRD, and NGC; and the websites of the following societies: ESC, ACC, ACEP, BTS, ACP, ATS, CTS and STS. The limits used were: human, subjects, 2000 -2009 . The studies included were RCTs, meta-analysis and systematic reviews (SR), and clinical guidelines (CPG). RESULTS: Thirty-nine documents out of 86 met inclusion criteria. The largest numbers of them included no systematic reviews, seven CPGs, nine RCTs, and eight SRs. There was great variability in the description of the risk factors associated with PE. When describing the clinical probability assessment tools, 30 describe the Wells score, 16 describe the Geneva score, and 8 describe others (Minniati, Kline, PIOPED, Perrier, and Wicki). One study even described its own score. All algorithms began by a clinical rule, but only eight of them specify the score to use.
DISCUSSION (CONCLUSION):
We have observed a high variability while using different algorithms and by the use of different imaging studies. Those algorithms are not justified by context differences. TARGET AUDIENCE(S): 1. Clinical researcher 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products 5. Quality improvement manager/facilitator 6. Health care policy analyst/policy-maker 7. Health insurance payers and purchasers 8. Medical providers and executives 9. Consumers and patients representatives
